Randomized Trial of an Intervention to Enhance Quality of Life in Adults Completing Lung Cancer Treatment With Curative Intent
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- Quality of life: Functional Assessment of Cancer Therapy-Lung Cancer
- Status
- Active, Not Recruiting
- Last Updated
- last month
Overview
Brief Summary
The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.
Detailed Description
This is a randomized controlled trial to test the efficacy of a brief psychoeducational intervention relative to a control condition for improving quality of life in patients with lung cancer who are transitioning from treatment to surveillance. In this study, participants will complete survey questions and will be randomly assigned to receive a 5-session program or a 1-session program. It is expected that about 100 people will take part in this research study. The American Lung Association is supporting this research by providing funding for the research study.
Investigators
Lara Traeger
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
Inclusion Criteria
- •Age 21 or older
- •Able to read and respond in English
- •Diagnosis of non-small cell lung cancer or small cell lung cancer
- •Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery
- •Completed cancer treatment within past 3 weeks
- •If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete
- •If final treatment is surgery: within 3 weeks after hospital discharge following surgery
Exclusion Criteria
- •Comorbid health condition that would interfere with study participation
- •Current participation in cognitive behavioral therapy treatment
Outcomes
Primary Outcomes
Quality of life: Functional Assessment of Cancer Therapy-Lung Cancer
Time Frame: Up to 12 weeks
We will investigate longitudinal differences in quality of life between study groups (Functional Assessment of Cancer Therapy-Lung Cancer score range 0-144, with higher scores indicating better quality of life)
Secondary Outcomes
- Fear of cancer recurrence: Fear of Cancer Recurrence Scale 7(Up to 12 weeks)
- Symptom burden: Edmonton Symptom Assessment Scale(Up to 12 weeks)
- Psychological symptom burden: Hospital Anxiety and Depression Scale(Up to 12 weeks)
- Social support: Multidimensional Scale of Perceived Social Support(Up to 12 weeks)
- Social isolaton: Campaign to End Loneliness Measurement Tool(Up to 12 weeks)